| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-14 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-13 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-13 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-13 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-12 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |